menu search

Why is bioxcel therapeutics (btai) stock down 57% today?

BioXcel Therapeutics (NASDAQ: BTAI ) stock is taking a beating on Thursday after the company released its latest clinical trial data. BioXcel Therape...

June 29, 2023, 8:57 am

Bioxcel therapeutics's drug meets key trial goal to treat alzheimer's patients

BioXcel Therapeutics said on Thursday its experimental drug to treat agitation related to alzheimer's d...

June 29, 2023, 6:20 am

Neuronascent to present new parkinson’s model data at aaic 2023 for the alzheimer’s disease investigational therapy, nni-362

ROCKVILLE, Md., June 28, 2023 (GLOBE NEWSWIRE) — Neuronascent Inc., today announced its abstract titled, Clinical Stage ...

June 28, 2023, 10:00 am

Longeveron files registration statement for rights offering

MIAMI, June 27, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company d...

June 27, 2023, 10:07 pm

Cognition therapeutics to host call and webcast to discuss topline results from ct1812 phase 2 sequel study on june 28, 2023

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage neuroscience company developing drugs that t...

June 27, 2023, 7:17 pm

Ac immune's stock soars 13% after fda grants fast-track designation to alzheimer's treatment

AC Immune SA's stock ACIU, +4.21% soared 13% premarket Tuesday, after the Swiss-based biotech said it has received U.S. Food and Drug Administration f...

June 27, 2023, 7:52 am

Biovie presents phase 3 study of alzheimer's treatment at san diego medical conference

BioVie Inc (NASDAQ:BIVI) announced that baseline data from a multicenter, randomized, placebo-controlled Phase 3 study of its ...

June 26, 2023, 9:11 am

Biovie: not investible for its alzheimer's program

BioVie: Not Investible For Its alzheimer's Program...

June 23, 2023, 4:49 pm

Biovie to present phase 3 study data at american diabetes association conference

BioVie Inc (NASDAQ:BIVI) said it will present an abstract showcasing baseline data from its Phase 3 study (NCT04669028) of NE3107 in patients with mi...

June 21, 2023, 9:17 am

Cognition therapeutics invited to participate on panel during cantor fitzgerald brain week 2023 on novel alzheimer’s disease approaches

PURCHASE, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today...

June 20, 2023, 11:30 am

Anavex life sciences to present at the h.c. wainwright 4th annual neuropsychiatry virtual conference

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmac...

June 20, 2023, 7:30 am

Does this signal trouble for biogen's new alzheimer's drug?

Some European alzheimer's experts are wary about the future of Biogen's drug Leqembi in the region. Reg...

June 19, 2023, 5:30 am

3 top stocks to buy and hold for the next decade

Brookfield boasts high-quality assets spanning wind, solar, hydroelectric, and other sustainable projects. Eli Lilly is staking out dominant positions...

June 16, 2023, 10:15 am

Aptamer surges on breakthrough in development of alzheimer's early diagnosis test

Aptamer Group PLC (AIM:APTA) shares surged over 200% higher in morning trade after the firm and Neuro-Bio, an Oxford-based biotech, announced a break...

June 14, 2023, 4:19 am

Biogen has been an 'uninvestable' stock for awhile, says mizuho's jared holz

Jared Holz, Mizuho Securities healthcare sector specialist, joins 'Fast Money' to talk controversy brewing at Biogen, ...

June 13, 2023, 6:36 pm

Vast utility for weight loss drugs will more than pay for themselves, says eli lilly ceo david ricks

Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's ...

June 13, 2023, 2:34 pm

European alzheimer's experts unconvinced by new eisai, biogen drug

alzheimer's disease experts in Europe weighing potential use of a new drug from Eisai and Biogen say it...

June 13, 2023, 3:16 am

Futures rise as focus shifts to inflation data, fed meet

U.S. stock index futures rose on Monday ahead of inflation data and the Federal Reserve’s interest rate decision this week, while Biogen shares gain...

June 12, 2023, 3:44 pm

New publication highlights basic science supporting simufilam

Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting Simufilam. Published in Drug Development Rese...

June 12, 2023, 1:15 pm

Biogen (biib), eisai alzheimer drug gets fda panel endorsement

An FDA advisory committee supports granting full approval to Biogen (BIIB)/Eisai's alzheimer's disease ...

June 12, 2023, 10:28 am


Search within

Pages Search Results: